Skip to main content

Eventide Asset Management, LLC

SEC CIK
0001442891
Latest filing
Aug 14, 2026

CRVS holding history

Corvus Pharmaceuticals, Inc. in every 13F filed by Eventide Asset Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CRVS overviewAll 13F holders of CRVSFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
1
Since Q1 2026
Holdings of CRVS by Eventide Asset Management, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−550,000−100.0%Sold outHolders
Q1 2026550,000$8.05M0.1%+550,000NewHolders